Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1CWZF | ISIN: US8740602052 | Ticker-Symbol: TKDA
Siehe auch TAKEDA PHARMACEUTICAL CO LTD
Tradegate
27.06.25 | 09:08
12,700 Euro
-1,55 % -0,200
Branche
Pharma
Aktienmarkt
JAPAN
Singapur
1-Jahres-Chart
TAKEDA PHARMACEUTICAL CO LTD ADR Chart 1 Jahr
5-Tage-Chart
TAKEDA PHARMACEUTICAL CO LTD ADR 5-Tage-Chart
RealtimeGeldBriefZeit
12,80013,10013:03
12,70013,10027.06.

Aktuelle News zur TAKEDA PHARMACEUTICAL CO LTD ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrTurnstone, once allied with AbbVie and Takeda, accepts $8M Xoma buyout8
MiADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?9
TAKEDA PHARMACEUTICAL CO LTD ADR Aktie jetzt für 0€ handeln
MiTAKEDA PHARMACEUTICAL CO LTD - 20-F, Annual and transition report of foreign private issuers8
MiTAKEDA PHARMACEUTICAL CO LTD - 6-K, Report of foreign issuer3
MiTAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::TAKEDA ANNOUNCES NEW ASSIGNMENTS OF DIRECTORS3
MiTAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::NOTICE OF RESOLUTIONS AT THE 149TH ORDINARY GENERAL MEETING OF SHAREHOLDERS4
17.06.With FDA nod for HAE drug Andembry, CSL set to compete with Takeda's Takhzyro6
17.06.Takeda's VP to Quit Japanese Drugmaker to Join Chinese Rival BeiGene, Sources Say12
12.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::SHARE REPURCHASE REPORT (FROM MAY 1, 2025 TO MAY 31, 2025)3
10.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::NOTICE CONCERNING DISPOSAL OF TREASURY SHARES - LTIP FOR COMPANY GROUP EMPLOYEE OUTSIDE OF JAPAN4
06.06.TAKEDA PHARMACEUTICAL CO LTD - 6-K, Report of foreign issuer6
06.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::STATEMENT CHAIR OF TAKEDA BOD IN RESPONSE TO ISS VOTING RECOMMENDATIONS AHEAD OF THE ORDINARY GMS3
05.06.EQS Newswire: Best Places to Work: Takeda Ukraine & Bulgaria Earn #8 Global Ranking in Best Places to Work 2024426EQS Newswire / 05/06/2025 / 11:30 CET/CEST LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized...
► Artikel lesen
04.06.Takeda receives EC approval for Adcetris combination in Hodgkin lymphoma15
04.06.EC approves Takeda ADC plus chemo for stage IIb Hodgkin's lymphoma10
03.06.Takeda, Pfizer's Adcetrix wins EU approval for hodgkin lymphoma treatment16
03.06.Takeda's ADCETRIS Combo Approved In EU For Advanced Hodgkin Lymphoma372TOKYO (dpa-AFX) - Takeda (TAK), Tuesday announced that the European Commission has approved ADCETRIS combined with etoposide, cyclophosphamide, doxorubicin, dacarbazine, and dexamethasone for...
► Artikel lesen
03.06.EU approves Takeda's new Hodgkin lymphoma treatment3
03.06.Takeda Pharmaceutical Company Limited: European Commission Approves ADCETRIS (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD536Approval Based on Positive Results from the Phase 3 HD21 Trial for Stage IIb with Risk Factors/III/IV Hodgkin Lymphoma ADCETRIS-based Combination Demonstrated Superior Safety Profile and Efficacy...
► Artikel lesen
03.06.Infrareal übernimmt Takedas Pharma- und Biotech-Standort in Orth6
Weiter >>
145 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1